Controversies in the treatment of sepsis

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Sepsis is a common illness of intensive care unit patients that carries a high morbidity, mortality, and increases hospital cost. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. Many interventions, such as early appropriate antibiotic therapy and lung protective, low tidal volume ventilation are commonplace and carry little controversy in their benefit. However, other therapies still have an unclear benefit and remain controversial. This article discusses the controversial roles of intensive insulin therapy, corticosteroids, and activated protein C in the treatment of sepsis.

Original languageEnglish (US)
Pages (from-to)66-78
Number of pages13
JournalSeminars in Respiratory and Critical Care Medicine
Volume31
Issue number1
DOIs
StatePublished - 2010

Fingerprint

Sepsis
Therapeutics
Mortality
Hospital Costs
Tidal Volume
Protein C
Critical Illness
Intensive Care Units
Adrenal Cortex Hormones
Guidelines
Insulin
Anti-Bacterial Agents
Morbidity
Lung

Keywords

  • Activated protein C
  • Corticosteroids
  • Glucose control
  • Insulin
  • Sepsis
  • Septic shock

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Controversies in the treatment of sepsis. / Sandrock, Christian E; Albertson, Timothy E.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 31, No. 1, 2010, p. 66-78.

Research output: Contribution to journalArticle

@article{2097665c70d1483bba8d9387df9fbc31,
title = "Controversies in the treatment of sepsis",
abstract = "Sepsis is a common illness of intensive care unit patients that carries a high morbidity, mortality, and increases hospital cost. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. Many interventions, such as early appropriate antibiotic therapy and lung protective, low tidal volume ventilation are commonplace and carry little controversy in their benefit. However, other therapies still have an unclear benefit and remain controversial. This article discusses the controversial roles of intensive insulin therapy, corticosteroids, and activated protein C in the treatment of sepsis.",
keywords = "Activated protein C, Corticosteroids, Glucose control, Insulin, Sepsis, Septic shock",
author = "Sandrock, {Christian E} and Albertson, {Timothy E}",
year = "2010",
doi = "10.1055/s-0029-1246290",
language = "English (US)",
volume = "31",
pages = "66--78",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Controversies in the treatment of sepsis

AU - Sandrock, Christian E

AU - Albertson, Timothy E

PY - 2010

Y1 - 2010

N2 - Sepsis is a common illness of intensive care unit patients that carries a high morbidity, mortality, and increases hospital cost. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. Many interventions, such as early appropriate antibiotic therapy and lung protective, low tidal volume ventilation are commonplace and carry little controversy in their benefit. However, other therapies still have an unclear benefit and remain controversial. This article discusses the controversial roles of intensive insulin therapy, corticosteroids, and activated protein C in the treatment of sepsis.

AB - Sepsis is a common illness of intensive care unit patients that carries a high morbidity, mortality, and increases hospital cost. Although mortality from sepsis remains high when compared with other critical illnesses, it has declined over the last few decades due to several adjunctive therapies and focused care programs or guidelines. Many interventions, such as early appropriate antibiotic therapy and lung protective, low tidal volume ventilation are commonplace and carry little controversy in their benefit. However, other therapies still have an unclear benefit and remain controversial. This article discusses the controversial roles of intensive insulin therapy, corticosteroids, and activated protein C in the treatment of sepsis.

KW - Activated protein C

KW - Corticosteroids

KW - Glucose control

KW - Insulin

KW - Sepsis

KW - Septic shock

UR - http://www.scopus.com/inward/record.url?scp=76749165340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749165340&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1246290

DO - 10.1055/s-0029-1246290

M3 - Article

C2 - 20101549

AN - SCOPUS:76749165340

VL - 31

SP - 66

EP - 78

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 1

ER -